Primary effusion lymphoma Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

1Recruiting trials

🩺

19Specialists

Regulatory Watchboard

2 events

Jun 2019CARDEC-PEL: Comparison of Two Methods of Caries Risk Assessment in Children

Federal University of Pelotas — NA

TrialRECRUITING

Jul 2017Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

National Cancer Institute (NCI) — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Primary effusion lymphoma.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1PHASE1, PHASE2

1Total recruiting

Search clinical trials for Primary effusion lymphoma →

Recent News & Research

No recent news articles indexed yet for Primary effusion lymphoma.
Search PubMed for Primary effusion lymphoma →

Browse all Primary effusion lymphoma news →

Specialist Network

Top 6 by expertise

Robert Yarchoan, M.D.

National Cancer Institute (NCI)

📍 Bethesda, Maryland

Score 3213 trials

Ramya M Ramaswami, M.D.

National Cancer Institute (NCI)

📍 Bethesda, Maryland

Score 2310 trials

Pei Wang, PhD

Eureka Therapeutics Inc.

Score 144 trials

Richard F. Little, MD

NCI - HIV and AIDS Malignancy Branch

Score 121 trial

Wyndham H Wilson, M.D., MD, PhD

National Cancer Institute (NCI)

📍 BETHESDA, MD

Score 118 trials

Stephen M Ansell, M.D

Dana-Farber - Harvard Cancer Center LAO

📍 ROCHESTER, MN

Score 101 trial5 pubs

View all Primary effusion lymphoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰